Related Experiment Video
Updated: Jun 5, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Developing an integrated Memory Assessment and Support Service for people with dementia
1School of Health and Social Care, Bournemouth University, Dorset Operational Services Manager, Crystal Centre, Essex, UK. shean@bournemouth.ac.uk
Journal of Psychiatric and Mental Health Nursing
|January 11, 2011
Summary
This study details a new integrated Memory Assessment and Support Service, aligning with national dementia care guidelines. Evaluation shows the service effectively improves dementia support and patient outcomes.
Area of Science:
- Gerontology
- Healthcare Management
- Public Health Policy
Background:
- Previous memory assessment services lacked integration and comprehensive support.
- A National Dementia Strategy (Department of Health) highlighted the need for improved dementia care pathways.
- Existing service models required enhancement to meet evolving patient needs.
Purpose of the Study:
- To describe the development of an integrated Memory Assessment and Support Service.
- To evaluate the effectiveness of the new service against previous provision.
- To offer recommendations for similar practice development initiatives.
Main Methods:
- Development of an integrated service based on best practice principles.
- Review and comparison of previous service provision models.
- Quantitative and qualitative evaluation of the new service's effectiveness.
Main Results:
- The integrated service demonstrated improved patient outcomes and satisfaction.
- Quantitative data indicated enhanced efficiency and accessibility.
- Qualitative feedback highlighted positive experiences for patients and caregivers.
Conclusions:
- The integrated Memory Assessment and Support Service is an effective model for dementia care.
- Adherence to best practice principles and national strategies is crucial for successful service development.
- The findings provide a valuable framework for other organizations developing similar services.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...